inner ear

Biotech Startup Receives $2M NIH Grant for Drug Development to Prevent Antibiotic-Related Hearing Loss

SEATTLE, WASHINGTON — Oricula Therapeutics, LLC, a biotech startup firm based in Seattle, announced today that it has received a Phase 2 Grant of approximately $2 million dollars from the Small Business Innovation Research (SBIR) program through the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH). The award funds will support…

Read More